Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, October 23, 2020
[ Fri, Oct 23rd 2020
] - WOPRAI
[ Fri, Oct 23rd 2020
] - WOPRAI
[ Fri, Oct 23rd 2020
] - WOPRAI
[ Fri, Oct 23rd 2020
] - WOPRAI
[ Fri, Oct 23rd 2020
] - WOPRAI
[ Fri, Oct 23rd 2020
] - WOPRAI
[ Fri, Oct 23rd 2020
] - WOPRAI
[ Fri, Oct 23rd 2020
] - WOPRAI
[ Fri, Oct 23rd 2020
] - WOPRAI
[ Fri, Oct 23rd 2020
] - WOPRAI
[ Fri, Oct 23rd 2020
] - WOPRAI
[ Fri, Oct 23rd 2020
] - WOPRAI
Thu, October 22, 2020
[ Thu, Oct 22nd 2020
] - WOPRAI
[ Thu, Oct 22nd 2020
] - WOPRAI
[ Thu, Oct 22nd 2020
] - WOPRAI
[ Thu, Oct 22nd 2020
] - WOPRAI
[ Thu, Oct 22nd 2020
] - WOPRAI
[ Thu, Oct 22nd 2020
] - WOPRAI
[ Thu, Oct 22nd 2020
] - WOPRAI
[ Thu, Oct 22nd 2020
] - WOPRAI
[ Thu, Oct 22nd 2020
] - WOPRAI
[ Thu, Oct 22nd 2020
] - WOPRAI
[ Thu, Oct 22nd 2020
] - WOPRAI
[ Thu, Oct 22nd 2020
] - WOPRAI
[ Thu, Oct 22nd 2020
] - WOPRAI
[ Thu, Oct 22nd 2020
] - WOPRAI
[ Thu, Oct 22nd 2020
] - WOPRAI
[ Thu, Oct 22nd 2020
] - WOPRAI
Matt Miksic Maintained (ABT) at Buy with Decreased Target to $118 on, Oct 22nd, 2020
Matt Miksic of Credit Suisse, Maintained "Abbott Laboratories" (ABT) at Buy with Decreased Target from $136 to $118 on, Oct 22nd, 2020.
Matt has made no other calls on ABT in the last 4 months.
There are 8 other peers that have a rating on ABT. Out of the 8 peers that are also analyzing ABT, 0 agree with Matt's Rating of Hold.
These are the ratings of the 8 analyists that currently disagree with Matt
- Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $120 on, Wednesday, October 21st, 2020
- Joshua Jennings of "TD Cowen" Maintained at Buy with Decreased Target to $113 on, Monday, October 19th, 2020
- Robbie Marcus of "JP Morgan" Maintained at Buy with Increased Target to $125 on, Friday, October 9th, 2020
- Mike Polark of "Wolfe Research" Initiated at Buy and Held Target at $124 on, Friday, September 11th, 2020
- Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $130 on, Friday, August 28th, 2020
- Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $115 on, Thursday, August 27th, 2020
- David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $125 on, Thursday, July 23rd, 2020
- John Sourbeer of "UBS" Maintained at Strong Buy with Increased Target to $110 on, Friday, July 17th, 2020
